Acute expression of E7 oncogene from human papillomavirus (HPV) 16 or HPV18 is sufficient to overcome tumor necrosis factor (TNF)-a cytostatic effect on primary human keratinocytes. In the present study, we investigated the molecular basis of E7-induced TNF resistance through a comparative analysis of the effect of this cytokine on the proliferation and global gene expression of normal and E7-expressing keratinocytes. Using E7 functional mutants, we show that E7-induced TNF resistance correlates with its ability to mediate pRb degradation and cell transformation. On the other hand, this effect does not depend on E7 sequences required to override DNA damage-induced cell cycle arrest or extend keratinocyte life span. Furthermore, we identified a group of 66 genes whose expression pattern differs between normal and E7-expressing cells upon cytokine treatment. These genes are mainly involved in cell cycle regulation suggesting that their altered expression may contribute to sustained cell proliferation even in the presence of a cytostatic stimulus. Differential expression of TCN1 (transcobalamin I), IFI44 (Interferon-induced protein 44), HMGB2 (high-mobility group box 2) and FUS [Fusion (involved in t(12; 16) in malignant liposarcoma)] among other genes were further confirmed by western-blot and/or real-time polymerase chain reaction. Moreover, FUS upregulation was detected in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with normal cervical tissue. Further evaluation of the role of such genes in TNF resistance and HPVassociated disease development is warranted.
Introduction
Persistent infection by high-risk human papillomaviruses (HPVs) types (i.e. HPV16 and -18) represents the major etiologic factor in the development of cervical intraepithelial neoplasia (1) , which, in turn, may progress to in situ and invasive carcinomas.
The time elapsed between initial infection and viral clearance as well as the development of HPV-related lesions is influenced by local cell-mediated immune response (2) . Tumor necrosis factor (TNF)-a is one of the main mediators of skin and mucosa inflammation and has a potent antiproliferative effect on normal epithelial cells. Numerous observations indicate that TNF may influence the fate of HPVinfected cells. For instance, this cytokine downregulates HPV16 E6/ E7 messenger RNA (mRNA) transcription in HPV16-immortalized human keratinocytes (3) and inhibits HPV18 oncogene expression in non-tumorigenic HeLa/fibroblast hybrids (4, 5) . Conversely, tumorigenicity of HeLa/fibroblasts hybrids and HPV16-transformed human keratinocytes has been correlated with TNF resistance (4) (5) (6) . Moreover, we have previously reported that TNF inhibits primary human keratinocytes (PHKs) and HPV16-immortalized keratinocytes proliferation, whereas HPV18-immortalized keratinocytes and HPVtransformed cell lines are resistant to this cytokine (6, 7) . TNF-mediated cell proliferation inhibition of PHKs and HPV16-immortalized keratinocytes was associated with the downregulation of mitotic regulatory proteins cyclin A, cyclin B and p34 cdc2 (7) and with NF-jB activation (8) . None of these effects was observed in HPV18 immortalized cells (7, 8) . Importantly, we have shown that differences in TNF response of normal and HPV16 or 18 immortalized human keratinocytes are reflected in alterations of global gene expression profiles (8) . These observations suggest that HPVmediated TNF resistance is a key event in the multi-step process leading to cervical cancer.
Results from recent studies indicate that E7 from high-risk HPV types is essential for mediating TNF resistance since HPV16 or 18 E7-expressing PHK are resistant to the antiproliferative effect of this cytokine (9, 10) . The aim of our study was to investigate the molecular basis of E7-induced TNF resistance. To achieve this goal, we performed a comparative analysis of the effect of this cytokine on the proliferation and global gene expression of organotypic cultures obtained from normal PHKs transduced with control vector or wild-type HPV16 E7. Moreover, we have studied the effect of TNF on cultures of PHKs transduced with E7 mutants carrying alterations in the main functional regions of the gene. We show that HPV16 E7 confers resistance to TNF in a culture system that faithfully reproduce HPVhost interaction (11) and that this effect requires sequences involved in pRb degradation and cell transformation. In addition, we identified a group of 66 genes which expression pattern differs between normal and E7-expressing cells upon cytokine treatment. Importantly, most of these genes are involved in the regulation of different phases of the cell cycle. Among them, TCN1 (transcobalamin I), IFI44 (Interferoninduced protein 44), HMGB2 (high-mobility group box 2) and FUS/ TLS [Fusion (involved in t(12;16) in malignant liposarcoma)/ translocated in liposarcoma] have not been previously linked to E7 expression. Upregulation of FUS was also observed in HPV-positive cervical high-grade squamous intraepithelial lesions when compared with normal cervical tissue. Our results suggest that E7 expression overcomes TNF cytostatic effect by differentially regulating a group of proliferation-related genes.
Materials and methods
Retroviruses, cells and organotypic raft cultures Low passage-pooled neonatal foreskin keratinocytes (Lonza Walkersville, Inc., Walkersville, MD) were grown in serum-free medium (Invitrogen, Frederick, MD). Cells were acutely infected with recombinant pLXSN retroviruses expressing the neomycin resistance marker. After 24 h, the cells were selected with 300 lg/ml of G418 for 2 days, when 100% of mocked infected controls were dead. Surviving cells were amplified and used to seed the epithelial raft or monolayers cultures. Recombinant pLXSN retrovirus vectors either empty or containing HPV16 E7 wild-type or mutant sequences (H2P, D6-10, D21-24, D21S, E26G, CVQ68-70AAA and D79-83) were kindly provided by Dr. Denise Galloway (Fred Hutchinson Cancer Research Center, Seattle, WA) and are described elsewhere (12) . After 9 days at the medium-air interface, raft cultures were treated with 2 nM TNF (Roche Applied Science, Indianapolis, IN) for 72 h. The nucleotide analog bromodeoxiuridine (BrdU) was added at 50 lg/ml for the last 12 h.
Cell proliferation assay
In organotypic cultures, the percentage of BrdU-positive nuclei was determined using [(BrdU-positive nuclei/total nuclei) Â 100]. Total and BrdU-positive nuclei numbers were determined by direct counting on rafts sections representing at least two independent experiments (.2000 nuclei per condition and per experiment). For monolayer cultures, low-density cultures of PHK infected with different recombinant retroviruses were treated with 2 nM TNF for 60 h. [Methyl-
3 H]thymidine was added at 1 lCi/ml (6,7 Ci/mmol) (GE Healthcare Lifesciences, Buckinghamshire, UK) for 12 h before harvesting. After extensive washing, counts per minute (CPM) were determined with a LS 6500 Multi-Purpose Scintillation Counter (Beckman Coulter TM , Brea, CA). Data were plotted as incorporation percentage with standard errors of triplicate repeats. Each independent experiment was repeated at least three times.
Protein extraction and immunoblotting
Total protein extracts were obtained as described previously (10) . Twenty-five micrograms of proteins were resolved by electrophoresis through sodium dodecyl sulfate-(10-12%) polyacrylamide gels and transferred to polyvinylidene difluoride membranes (Amersham Pharmacia Biotech, Buckinghamshire, UK) using the Mini Trans-blot Electrophoretic Transfer system (Bio-Rad Laboratories, Hercules, CA). Membranes were blocked for 1 h in 5% non-fat milk and probed for 1-2 h with a 1:1000 dilution of the following primary antibodies: NCL-cyclin A and NCL-p27 (Novocastra, Newcastle upon Tyne, UK), anti-FUS/translocated in liposarcoma (sc-47711, Santa Cruz Biotechnology, Santa Cruz, CA), anti-MCM2 (D1.9H5, AbCam, Cambridge, MA), anti-PCNA (18-0110, Zymed Laboratories, San Francisco, CA) and anti-tubulin (T-9026; Sigma-Aldrich, St. Louis, MO). Membranes were then washed and reprobed with horseradish peroxidase-conjugated secondary antibodies (Amersham Pharmacia Biotech). The bands were revealed using Enhanced Chemiluminescence procedures according to the manufacturer's recommendations (Amersham Pharmacia Biotech).
Immunohistochemical and immunofluorescence procedures
BrdU incorporation in organotypic cultures was detected as described previously (10) using a monoclonal anti-BrdU antibody (#18-0103, Zymed Laboratories; 1:100 dilution). Nine biopsies from patients with HPV16-positive high-grade squamous intraepithelial lesions (HSILs) or squamous cell carcinoma (SCC) were analyzed for FUS expression. These samples were derived from an epidemiological study of immune response against HPV approved by institutional review boards. Antigen retrieval was performed by incubation of 4 lm deparaffinized sections in 10 mM citrate buffer (pH 6) at 95°C for 10 min. FUS was detected using a mouse monoclonal antibody (sc-47711, Santa Cruz Biotechnology; 1:100 dilution) in conjunction with the Histostain-SP broadspectrum kit according to the manufacturer's instructions (Zymed Laboratories). The images were captured with an Olympix DP70 digital camera attached to an Olympus Provis IX70 microscope and digitally processed using Photoshop 7.0 (Adobe Systems, San Jose, CA).
RNA extraction, amplification, labeling and hybridization Total RNA was extracted using TRIzol Reagent (Life Technologies, Grand Island, NY) following the manufacturer's instructions. Isolated RNA was treated with the RNase-Free DNase Set (Qiagen, Valencia, CA) on RNeasy Mini Kit columns (Qiagen), according to the manufacturer's directions. Three micrograms of sample and reference (a pool of RNA from normal PHK grown in monolayer) total RNAs were linearly amplified using T7-based protocol, converted to amino allyl dUTP-modified complementary DNA (cDNA) and labeled with Alexa dyes (Alexa555, Alexa647) (Invitrogen, Molecular Probes, Carlsbad, CA) as described previously (13) . Hybridizations were performed in triplicate, using dye-swap, on a cDNA platform of ORESTES representing 4600 unique genes with known full-length sequence selected from the clone collection derived from the Human Cancer Genome Project (14) . A detailed description of the cDNA microarray platform used and the raw data of this study are available at the Gene Expression Omnibus web site under the accession numbers GPL1930 and GSE17892, respectively (15) . Slides were scanned on a confocal laser scanner ScanArray Express [(PerkinElmer Life Sciences, Waltham, MA) laser power 100%, PMT60 (Alexa555) e PMT70 (Alexa647)]. Data were extracted with the ScanArray Express software (PerkinElmer Life Sciences, Boston, MA) using the histogram method. Fluorescent intensities of Cy5 and Cy3 channels on each slide were subjected to spot filtering and normalization. We first eliminated all saturated points and performed a local background subtraction, considering for analysis only spots with positives values. Normalization was performed by using a locally weighted linear regression (LOWESS) within arrays.
Statistical analysis
For identification of differentially expressed genes between TNF-sensitive and TNF-resistant cells, we performed a (3 Â 2) analysis of variance test (P , 0.05). As an additional criterion, we analyzed differentially expressed genes with fold . 1.5. Moreover, gene expression changes between specific samples pairs were determined using the Student's t-test. Genes were classified according to biological processes through Gene Ontology (GO) using Web-based Gene Set Analysis Toolkit (WebGestalt) (16) . Functional processes were considered as significant when P , 0.05. Assessments, which were represented by only one gene, were not taken in consideration in order to avoid artifactual results. For clustering samples based on gene set expression profile, we applied supervised hierarchical clustering based on Euclidean distance and average linkage. Reliability of the clustering was assessed by the Bootstrap technique using TMEV software (17) .
Quantitative real-time reverse transcription-polymerase chain reaction Total cellular RNA was extracted from organotypic cultures as described above. The cDNA was synthesized from 1 lg of total RNA with reverse transcriptase using the oligo d(T) primer and ImProm-II Reverse Transcriptase (Promega, Madison, WI), following the manufacturer's instructions. Ten nanograms of cDNA from each sample was then subjected to polymerase chain reaction (PCR) amplification with specific forward (F) and reverse (R) primers-CCL20 F: 5#-GCTCCTGGCTGCTTTGATGT-3#, R: 5#-GAATAC-GGTCTGTGTATCCAAGACA-3#; DEK F: 5#-CCCGCGTCCGAGAAAGA-3#, R: 5#-TTGCCTTCCACGATGAGACTC-3#; HMGB2 F: 5#-GCTCTGCG-GGACTCTGAGG-3#, R: 5#-CGTACGAGGACATTTTGCCC-3#; IFI44 F: 5#-TACCAGTTTAATCCCATGGAATCA-3#, R: 5#-CAAATACAAATGCC-ACACAATGAA-3#; MCM5 F: 5#-CGTGTGGCAATCCACGAA-3#, R: 5#-AGCGGCCGAACACTGAGTT-3# and TCN1 F: 5#-TTCAGGGCCTAT-GTGCCAA-3#, R: 5#-TTGCGGACAACGTAACTACCAG-3#. The primers were designed using the PrimerExpress program (Applied Biosystems, Foster City, CA). Quantitative reverse transcription-polymerase chain reaction was performed using an ABI 7300 Real-Time PCR System and SYBR Green PCR Master Mix from Applied Biosystems. The expression level of glyceraldehyde 3-phosphate dehydrogenase was used to normalize the abundance of the tested transcripts. All quantitative reverse transcription-polymerase chain reactions were performed in triplicate for, at least, two independent experiments. The relative expression value was obtained from the difference (DCT) between target gene CT and glyceraldehyde 3-phosphate dehydrogenase CT. Final results were expressed as fold induction, compared with the reference sample, using the 2 ÀDCT formula (18). Student's t-test was employed to statistically evaluate the differences observed.
Results

HPV16 E7 confers resistance to TNF inhibition of S-phase entry in monolayer and raft cultures
In this study, we compared the effects of TNF on the proliferation of control and HPV16 E7-expressing PHKs grown in monolayer or in organotypic cultures. Subconfluent monolayer cultures of early passage PHKs transduced with recombinant retroviruses carrying the pLXSN empty vector (from now on referred as normal PHKs) or pLXSN vector with either wild-type or mutant HPV16 E7 gene were treated with 2 nM of TNF for 60 h. DNA synthesis/cell proliferation rate was then determined by 3 H-thymidine incorporation. As previously reported (6, 7, 9) , normal keratinocytes were highly sensitive to TNF antiproliferative effect (.60% proliferation inhibition), whereas PHKs-expressing wild-type HPV16 E7 were resistant to TNF cytostatic effect (5-15% proliferation inhibition) ( Figure 1A ).
Since pRb binding and destabilization is essential for HPV16 E7 cell cycle promoting capacity (19), we sought to check TNF effects on PHKs expressing a series of E7 mutants differing in their ability to mediate pRb degradation. Interestingly, we observed that PHKsexpressing E7 mutants unable to induce pRb degradation were as sensitive to this cytokine as normal PHKs. On the other hand, keratinocytes-expressing HPV16 E7 mutants that retain the capacity to mediate pRb degradation were resistant to TNF cytostatic effect (,15% proliferation inhibition) ( Figure 1A ).
Monolayer culture favors the proliferation of undifferentiated cells. However, E7 from both high and low-risk HPV types can induce S-phase re-entry in post-mitotic differentiated keratinocytes (20) .
Therefore, we decided to study TNF effect on the proliferation of keratinocytes grown in epithelial organotypic cultures, a system that reproduces epidermis architecture and keratinocyte differentiation program (11) . For this, the keratinocytes described above were seeded onto type I collagen dermal equivalents as described elsewhere (10,21). After 9 days at the air-liquid interface, cultures were treated with TNF for 72 h and exposed to BrdU for the last 12 h prior harvesting on day 12. BrdU incorporation was detected by immunohistochemistry ( Figure 1B ) and the percentage of BrdU-positive nuclei was determined by direct counting of BrdU-labeled and total nuclei in whole-raft sections ( Figure 1C ). In normal PHKs raft cultures, BrdU incorporation was restricted to cells from the basal/parabasal layers and labeled nuclei HPV16 E7-expression alters PHKs response to TNF accounted for $20% (19.4% ± 1.84) of total. However, the percentage of BrdU-positive nuclei dropped to almost 10% (10.5% ± 0.96) after TNF treatment. Conversely, in raft cultures of PHKs expressing the HPV16 E7 oncoprotein almost one-fourth (26.4% ± 2.47) of the nuclei were positive for BrdU staining and were observed in all cell strata. This is in agreement with previous reports showing that HPV16 or HPV18 E7 can sustain DNA synthesis in cells from the upper differentiated layers of the epithelium (21) (22) (23) (24) . Besides, in these cultures, the fraction of BrdU-positive nuclei was not affected by TNF treatment (27.2% ± 4.74). The results of BrdU incorporation quantification are presented in Figure 1C . These results indicate that HPV16 E7 confers resistance to TNF cytostatic effect in organotypic cultures.
Since our data from monolayer cultures suggest that E7-mediated resistance to TNF correlates with its capacity to induce pRb degradation, we further tested this hypothesis in organotypic cultures of keratinocytes-expressing HPV16 E7 E26G gene, an E7 mutant unable to induce pRb degradation. In these cultures, the pattern of BrdU incorporation was undistinguishable from that of normal PHKs with labeled nuclei detected exclusively in cells from the basal and parabasal layers of the epithelium (17.5% ± 2.52 BrdU-positive nuclei) ( Figure 1B and C) . Furthermore, as observed for normal PHKs cultures, the percentage of BrdU-positive nuclei was clearly reduced after TNF treatment (8.6% ± 0.62) ( Figure 1B and C) . Similar results were obtained using other HPV16 E7 mutants unable to induce pRb degradation (data not shown).
In order to characterize the involvement of other E7 domains in TNF resistance, we analyzed the effect of this cytokine on PHKs transduced with recombinant retroviruses containing HPV16 E7 carrying the CVQ68-70AAA or D79-83 mutations in the C-terminal region. These mutants retain the ability to destabilize pRb and the related pocket proteins p107 and p130, to compete with E2F for pRb binding and are efficient in bypassing pRb-induced quiescence. However, they are defective in overriding DNA damage-induced cell cycle arrest or extending keratinocyte life span (12) . Monolayer and organotypic cultures established from keratinocytes expressing these proteins exhibited proliferation/DNA-synthesis levels similar to those observed in cultures expressing the wild-type protein. Moreover, proliferation/DNA synthesis was not affected by TNF ( Figure 1A and D) . Altogether, our results show that HPV16 E7 confers resistance to TNF in organotypic cultures and that this effect is associated to the integrity of sequences required for mediating pRb degradation but not to those required to mediate DNA damage resistance and for increasing keratinocyte life span.
Identification of genes differentially expressed between TNF-sensitive and TNF-resistant cells
In order to identify differentially expressed genes between TNFsensitive and TNF-resistant cells, total RNA from untreated and TNF-treated normal (PHK_pLXSN), HPV16 E7wt-and HPV16 E7 E26G-expressing PHKs organotypic cultures was amplified and hybridized onto glass arrays containing 4600 cDNA human sequences. The identification of differentially expressed genes between normal, E7 E26G-and E7-expressing samples treated or not with TNF was performed by 3 Â 2 analysis of variance. Using this approach, we identified 93 differentially expressed genes with statistical significance (P , 0.05) between both TNF-sensitive cell lines (normal PHKs and E7 E26G) and TNF-resistant cells (E7 wt). From these genes, we further selected those that were up-or downregulated .1.5-fold in both comparisons giving a total of 41 genes (Figure 2) . The name and function of these genes are listed in Table I . These genes were grouped in functional categories according to the Gene Ontology Tree Machine database (http://bioinfo .vanderbilt.edu/gotm). This analysis showed that most of the differentially expressed genes identified belong to functional categories associated with regulation of cell proliferation and cell cycle progression (supplementary Table 1 is available at Carcinogenesis Online).
Identification of genes differentially regulated by TNF between normal and E7-expressing PHK In order to identify differentially expressed genes between specific samples and experimental conditions, we performed a series of pairwise comparisons. For each pair-wise comparison, we generated a list of differentially expressed genes with P , 0.05 and fold . 2. To get insights into the molecular mechanisms underlying E7-induced resistance to TNF cytostatic effect, we sought to characterize genes that were differentially expressed between normal and E7-expressing keratinocytes upon cytokine treatment. For this purpose, we performed two pair-wise comparisons: (i) between Normal and E7 Fig. 2 . Identification of differentially expressed genes that differentiate TNF-sensitive from TNF-resistant cell lines. The identification of differentially expressed genes between normal and E7-expressing samples, as well as between E7 E26G-and E7-expressing samples was performed by 3 Â 2 analysis of variance (P , 0.05). From these genes, we further selected those that were up-or downregulated .1.5-fold in both comparisons giving a total of 41 genes. Higher gene expression is shown in red, low gene expression is shown in green and black indicates non-differential gene expression.
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samples and (ii) between Normal_TNF and E7_TNF samples. Two lists, consisting of 51 and 66 genes for the first and second comparisons, respectively, were obtained and compared. We observed that 28 genes were common to both lists, 23 genes were differentially expressed only between Normal and E7 samples and 38 genes were differentially expressed exclusively between Normal_TNF and E7_TNF samples. The name, P-values and fold-induction factor of the 66 genes differentially expressed between TNF-treated samples are listed in Table II . These genes were grouped in functional categories according to the Gene Ontology Tree Machine as described above. We observed that gene numbers in 58 GO categories were relatively enriched (P , 0.01). Interestingly, most of these categories were associated with DNA metabolism and cell cycle regulation. A chart showing the number of differentially expressed genes between Normal_TNF and E7_TNF samples identified in each functional category is depicted in Figure 3 . As can be observed, the majority of the genes associated with these functional categories were upregulated in E7-expressing keratinocytes despite cytokine treatment. Note that each gene may appear in more than one category. The complete list of observed and expected gene number for each functional category as well as the corresponding P-values is presented in supplementary Table 2 (available at Carcinogenesis Online). Similar results were obtained when the same analysis was performed with the 38 genes, which exhibited a differential expression profile exclusively between Normal_TNF and E7_TNF samples. In this case, we observed enriched gene numbers in 19 GO categories (P , 0.01) mainly associated to DNA metabolism and cell cycle regulation (supplementary Table 3 is available at Carcinogenesis Online). Interestingly, only 3 (CXXC1, FAM38A and TTC35) of these 38 genes were found as differentially expressed between Normal and Normal_TNF samples and just one (TNFSF10) was differentially expressed between E7 and E7_TNF samples. Altogether, these results show that E7-expressing cells respond to TNF by regulating a different set of genes and that viral oncogene expression upregulates several genes associated to cell cycle progression even in the presence of a cytostatic stimulus. The mRNA levels of CCL20, IF44, TCN1, HMGB2 and DEK were analyzed by quantitative real-time PCR. The data presented in Figure 4A confirm the microarray results. The expression of the CCtype chemokine CCL20 was highly induced by TNF treatment in both TNF-sensitive cell lines. On the other hand, the basal levels of CCL20 were lower in E7-expressing PHKs and the levels reached after TNF exposure were at least 4-fold lower than those observed for normal or E7 E26G-expressing cells. The levels of IFI44 mRNA, which codifies the interferon-induced protein 44, were higher and were induced to a greater extent by TNF in normal PHKs than in E7-expressing cells. Interestingly, E7 E26G-expressing PHKs exhibited higher basal levels of this transcript than normal cells and were not affected by cytokine treatment. The levels of the mRNA coding for the member of the vitamin B12-binding protein family TCN1 was downregulated in E7-expressing keratinocytes. Conversely, the levels of mRNA coding for the proto-oncogene DEK and for the architectural DNA binding and bending factor HMGB2 were upregulated in E7-expressing cells.
The expression levels of cyclin A, PCNA, p27 kip1 , MCM2 and FUS were determined by western blot using total protein extracts obtained from organotypic cultures ( Figure 4B ).
Cyclin A and PCNA are required for S-phase progression and DNA replication, respectively. After treatment with TNF, we observed a reduction in the levels of these two proteins in the raft cultures derived from normal or E7 E26G-expressing PHKs, which are sensitive to this cytokine. Conversely, these proteins levels were higher in extracts from raft cultures expressing HPV16 E7 and were not affected by TNF treatment ( Figure 4B ).
The cyclin-dependent kinase inhibitor p27 kip1 binds and inhibits cyclin E/cdk2 and cyclin A/cdk2 complexes, thereby preventing cells from entering the S-phase (25) . Consistent with the microarray data (Tables I and II) , we observed that the levels of this protein are higher in E7-expressing PHKs and we detected no difference due to cytokine exposure ( Figure 4B ).
The expression of MCM2 and MCM5, two components of the MCM complex (minichromosome maintenance complex) which play an essential role in the initiation and elongation of DNA replication, was upregulated in E7-expressing keratinocytes when compared with normal cells in our microarray data set. Besides, MCM2 levels were also higher in E7-expressing cultures than in normal cells upon cytokine treatment. These observations were confirmed by western blot for MCM2 and by real-time PCR for MCM5 ( Figure 4A and B) .
FUS/translocated in liposarcoma is a nucleoprotein that functions in DNA and RNA metabolism. Its N-terminal half functions as a transcriptional activator domain in fusion oncoproteins found in human leukemias, liposarcomas and neurological disorders. Here, we show that this protein is expressed at basal levels in normal and E7 E26G-expressing PHKs and is upregulated in E7-expressing keratinocytes (Tables I and II and Figure 4B ). We then aimed to determine if upregulation of FUS occurs in vivo in HPV-related lesions. Therefore, we analyzed FUS expression levels in nine HPV16-positive cervical biopsies from patients with HSILs or SCC. A representative result is shown in Figure 4C . Upregulation of FUS was observed in all cases of HSIL and SCC when compared with normal tissue within the biopsies. In normal tissue, FUS was found in the nuclei of cells from the basal/ parabasal layers of the epithelium. In contrast, strong FUS-stained nuclei were found in 50-100% of the cells of the HSIL and SCC sections.
Discussion
In this study, we conducted a detailed analysis of the HPV16 E7 domains required for mediating TNF resistance. Besides, we performed a comparative analysis of global gene expression between normal and HPV16 E7-expressing PHK upon TNF treatment. Our results support the notion that TNF regulates a different set of genes in normal and in E7-expressing cells. Moreover, we provide evidence showing that E7 expression overcomes TNF effect through the upregulation of a group of genes associated with cell cycle progression.
First, we have established that HPV16 E7 confers resistance to the antiproliferative effect of TNF in organotypic and monolayer epithelial cell cultures (Figure 1) . Previous studies have shown that the ability of E7 to overcome TNF cytostatic effect on human keratinocytes grown in monolayer culture requires the integrity of the LxCxE sequence a protein domain involved in cell transformation and required to mediate pRb degradation (9) . Here, we extend this observation to the organotypic cellular context using several E7 mutants that differ in their capacity to target and degrade the key tumor suppressor pRb and the related pocket proteins p107 and p130 (12, 26) . Moreover, our results using the E7 mutants CVQ68-70AAA and D79-83 show that induction of TNF resistance can be uncoupled from E7's capacity to bypass DNA damage-induced cell cycle arrest and increasing normal human keratinocytes life span (12) .
We next addressed the differences in global gene expression between TNF-sensitive and TNF-resistant epithelial organotypic cultures. Our experimental setting allowed us to identify 41 genes that distinguish TNF-sensitive (normal and E7 E26G-expressing PHKs) from TNF-resistant cells (E7-expressing PHKs) and 66 genes that are differentially expressed between normal and E7-expressing samples upon cytokine treatment.
Gene ontology analysis showed that most of the differentially expressed genes identified belong to functional categories involved in DNA metabolism, regulation of mitosis, regulation of cell cycle and cell proliferation. Interestingly, most of the genes associated to these functional categories were upregulated in E7-expressing keratinocytes, which is in line with their enhanced proliferative activity. In 2004, Thierry et al. (27) studied the effect of reintroducing E2 in HPV18-associated cervical carcinoma cells and observed the downregulation of several mitotic genes including CCNA2, CCNB2, TOP2A, UBE2C and ZWINT. In our study, these genes were found as upregulated in E7-expressing cells (Tables I and II and Figure 4) . The increase in transcripts associated to DNA metabolism has been reported in organotypic cultures expressing HPV18 E6/E7 oncoproteins (28) . Moreover, upregulation of genes, such as CCNA2, CENPF, TACC3, TOP2A, MCM2 and MCM5 ( Figure 4 and Table II), in cells expressing HPV16 E7 has been previously observed by others (8, (28) (29) (30) . Our study further extends these observations to a system that combines cellular differentiation and the presence of an antiproliferative and proinflammatory stimulus. Besides, the reproducible upregulation by E7 of genes associated with DNA synthesis, as compared with other studies, further reassures that we are working with a relevant set of genes. Altogether, our results show that E7-expressing cells respond to TNF by regulating a different set of genes than normal PHKs. Moreover, we present evidence that viral oncogene induces several genes associated with cell cycle progression which upregulated expression may induce a cellular proliferative state that is refractory to the cytostatic stimulus imposed by cytokine treatment.
We then verified the differential expression of genes involved in the immune response that may provide relevant information on the virus biology and evasion mechanisms (Tables I and II) . For instance, we detected that E7-expressing cells exhibit lower levels of CAMP (LL-37) mRNA than normal keratinocytes. The a-helical antimicrobial peptide LL-37 is active at cutaneous wound sites, is expressed in genital tissues E.Boccardo et al. Fig. 4 . Analysis of differentially expressed genes described in Table I . (A) Real-time PCR analysis of selected genes was performed on total RNA samples from organotypic cultures of keratinocytes transduced with HPV16 E7wt, E7 E26G or pLXSN empty vector (normal). After 9 days at the liquid-air interface, raft cultures were treated with 2 nM TNF for 72 h or left untreated (control). Data are representative of three independent experiments. Statistical difference with untreated sample (asterisks), statistical difference with normal and E7 E26G samples (filled triangles) and statistical difference with Normal_TNF and E7 E26G_TNF samples (filled inverted diamonds) (P 0.05). (B) Western-blot analysis of total protein extracts from epithelial rafts. Organotypic cultures and culture conditions were the same as in (A). (C) FUS expression was analyzed by immunohistochemistry in cervical specimens. HPV16-positive cervical lesions exhibit higher FUS levels when compared with normal tissue within the biopsies; H-SIL, high-grade squamous intraepithelial lesion.
HPV16 E7-expression alters PHKs response to TNF and in HPV-associated skin warts and has been shown to inhibit HPV infection in vitro (31) (32) (33) (34) (35) . Interestingly, we found that expression of this gene is downregulated in organotypic cultures expressing HPV16 E7. Besides, we observed the upregulation of IL6R mRNA in E7-expressing cells. This gene mediates apoptosis resistance of colorectal carcinoma and myeloma cells through STAT1-and STAT3-regulated pathway, respectively (36, 37) . Finally, we observed the downregulation of interferon pathway-related genes IFI44, IFI44L and IFNGR1 in E7-expressing cultures. Obstruction of the interferon signaling pathway has been previously reported in systems harboring isolated high-risk HPV genes as well as complete genomes (29, (38) (39) (40) . Importantly, it has been reported that IFI44 overexpression causes cell cycle arrest in vitro (41) . Therefore, E7-mediated alteration in the expression levels of these genes may contribute to explain the differential effect of TNF on the proliferation of cells expressing this oncoviral protein.
Our microarray results also identified individual genes that may constitute potential biomarkers for HPV-associated lesions. For instance, we report the increased expression of FUS and HMGB2 as well as the downregulation of TNC1 in E7-expressing cells (Figure 4) . Besides, we further confirmed FUS overexpression in HPV16-positive cervical lesions ( Figure 4C ). Interestingly, FUS expression correlates with the proliferation marker CCNA2 in human embryonic stem cells. However, no upregulation of FUS was detected in proliferating F470 primary human fibroblasts or in serum-stimulated HT-1080 cells (42) . This discrepancy could reflect differences in the cell types analyzed. FUS belongs to the FET (FUS, EWSR1 and TAF15) family of RNA-binding proteins and is associated with transcription, splicing, micro-RNA processing, RNA transport, signaling and maintenance of genomic integrity (43, 44) . Besides, deregulated expression of members of this gene family as a result of chromosomal translocations has been associated to the development of specific types of cancer (45, 46) . Our results clearly demonstrate the upregulation and altered tissue expression pattern of this protein in E7-expressing cells and in HPV16-associated lesions. Several studies have addressed the value of proliferation markers such as p16 INK4A , MCM2, MCM5, CDC6, cyclin B1, D1 and of other RNAbinding proteins for diagnosis and prognosis of cervical and vulvar intraepithelial neoplasia (47) (48) (49) (50) . Determining the individual or combinatorial value of FUS expression as a molecular marker for cervical lesions diagnosis/progression warrants further studies.
Several critical events in HPV-associated diseases, such as establishment of persistent infections and development and progression of HPV-induced lesions, are the result of viral interference on host cell functions, such as response to proliferation regulatory stimulus. Our results show that expression of HPV16 E7 is sufficient to overcome TNF antiproliferative effect. Furthermore, we prove that this E7 effect is strictly dependent on the integrity of sequences required to mediate pRb degradation and can be uncoupled from other E7 properties, such as DNA damage-induced arrest resistance and keratinocytes life span extension. By microarray analysis, we have identified multiple genes differentially regulated by TNF between normal and E7-expressing keratinocytes and validated many of them. Some genes, i.e. TCN1 (transcobalamin I), IFI44 (interferon-induced protein 44), FUS [fusion (involved in t(12;16) in malignant liposarcoma)] and HMGB2 (high-mobility group box 2) have not been previously reported as differentially modulated in E7-expressing cells. These results may provide new insights on the molecular mechanisms of HPV-mediated cell transformation and immune evasion. Moreover, they may contribute to the identification of genes involved in HPV-associated disease establishment and/or progression.
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